OncoCyte Corp (OCX)
$2.42 -$0.08 (-3.20%) 12:12 PM 12/11/24
NASDAQ | $USD | Diagnostics & ResearchStock Data
-
Market Cap
$41.25M -
Day's Range
$2.33 - $2.49 -
Volume
153,094 -
52 Week Low / High
$1.98 - $3.82 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
OCX's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 0
- Strong Buy
- 1
- Buy
- 2
- Hold
- 0
- Sell
- 0
- Strong Sell
- $4.19
- Target Price
Company News
-
Oncocyte Appoints Andrea James as Chief Financial Officer — Jun 17th, 2024
OncoCyte Corporation IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to wel...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$